Jaguar Health, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Jaguar Health, Inc. (JAGX) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 22. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 11.3%, relative volume 1.26×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
2 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
JAGX is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -40.6% / -90.0%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JAGX Jan avg: -25.53% median: -29.02% win: 0% σ: 8.90% n: 4 2022-04-12 → 2026-05-29 | JAGX Feb avg: -24.81% median: -36.63% win: 25% σ: 39.25% n: 4 2022-04-12 → 2026-05-29 | JAGX Mar avg: -42.04% median: -60.71% win: 25% σ: 65.72% n: 4 2022-04-12 → 2026-05-29 | JAGX Apr avg: 407.07% median: 138.82% win: 60% σ: 771.27% n: 5 2022-04-12 → 2026-05-29 | JAGX May avg: -33.17% median: -48.99% win: 20% σ: 41.73% n: 5 2022-04-12 → 2026-05-29 | JAGX Jun avg: -24.86% median: -20.77% win: 0% σ: 12.26% n: 4 2022-04-12 → 2026-05-29 (current) | JAGX Jul avg: -17.88% median: -15.83% win: 25% σ: 37.49% n: 4 2022-04-12 → 2026-05-29 | JAGX Aug avg: -19.15% median: -14.31% win: 0% σ: 15.46% n: 4 2022-04-12 → 2026-05-29 | JAGX Sep avg: -1.18% median: -7.02% win: 50% σ: 38.13% n: 4 2022-04-12 → 2026-05-29 | JAGX Oct avg: -4.07% median: -13.56% win: 25% σ: 25.23% n: 4 2022-04-12 → 2026-05-29 | JAGX Nov avg: -9.03% median: -3.98% win: 25% σ: 14.76% n: 4 2022-04-12 → 2026-05-29 | JAGX Dec avg: -31.07% median: -32.09% win: 0% σ: 22.23% n: 4 2022-04-12 → 2026-05-29 |